Borrelia burgdorferi (Newton Laboratories, Inc.)
Welcome to the PulseAid listing for the Borrelia burgdorferi drug offered from Newton Laboratories, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Newton Laboratories, Inc. |
| NON-PROPRIETARY NAME: | Borrelia burgdorferi |
| SUBSTANCE NAME: | BORRELIA BURGDORFERI |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | LIQUID |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2011-09-01 |
| END MARKETING DATE: | 0000-00-00 |
Borrelia burgdorferi HUMAN PRESCRIPTION DRUG Details:
| Item Description | Borrelia burgdorferi from Newton Laboratories, Inc. |
| LABELER NAME: | Newton Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200([hp_C]/mL) |
| START MARKETING DATE: | 2011-09-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55714-6083_ec0dda76-af8a-252f-eee8-91753ef2144e |
| PRODUCT NDC: | 55714-6083 |
| APPLICATION NUMBER: | |
Other BORRELIA BURGDORFERI Pharmaceutical Manufacturers / Labelers:
